Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Aún no recluta
ClinicalTrials.gov
Lateral Cord Electrical Stimulation Can Improve Spasticity in Chronic Spastic Cerebral Palsy
INTERVENTIONAL
Inicio: 1 de jun de 2025
ID: NCT02199015
Completado
Fase 3
ClinicalTrials.gov
Medically Ill Patient Assessment of Rivaroxaban Versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk
INTERVENTIONAL
Inicio: 7 de ene de 2014
ID: NCT02111564
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
INTERVENTIONAL
Inicio: 11 de abr de 2011
ID: NCT01327846
Completado
Fase 3
ClinicalTrials.gov
A Randomized Double-Blind Placebo-Controlled Parallel Group Study of the Efficacy and Safety of XRP0038/NV1FGF on Amputation or Any Death in Critical Limb Ischemia Patients With Skin Lesions
INTERVENTIONAL
Inicio: 1 de nov de 2007
ID: NCT00566657
Completado
ClinicalTrials.gov
Airway Occlusion Measured During Non-invasive Ventilation to Assess Respiratory Effort
INTERVENTIONAL
Inicio: 30 de oct de 2022
ID: NCT05576246
Completado
ClinicalTrials.gov
Longitudinal Study of Young Patients With Embolic Stroke of Undetermined Source (ESUS)
OBSERVATIONAL
Inicio: 15 de feb de 2017
ID: NCT03185520
Completado
ClinicalTrials.gov
The Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis
OBSERVATIONAL
Inicio: 15 de oct de 2011
ID: NCT01285479
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Open-Label, Multi-Center Study Evaluating the Efficacy, Safety and Pharmacokinetics of Genz-112638 in Gaucher Type 1 Patients
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00358150
Completado
Fase 2
ClinicalTrials.gov
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
INTERVENTIONAL
Inicio: 1 de sept de 2000
ID: NCT00044278
Completado
Fase 2
ClinicalTrials.gov
A Phase 1/2, Open-Label, Repeat-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children at Risk for Serious RSV Disease
INTERVENTIONAL
Inicio: 1 de feb de 2004
ID: NCT00192478
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Individuals With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
INTERVENTIONAL
Inicio: 8 de oct de 2025
ID: NCT07140913
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Participants With Systemic Lupus Erythematosus (SLE)
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01196091
Terminado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of 12 Months of Therapy With Inhaled Colistimethate Sodium in Subjects With Non-cystic Fibrosis Bronchiectasis Chronically Infected With P. Aeruginosa
INTERVENTIONAL
Inicio: 29 de ene de 2018
ID: NCT03460704
Completado
Fase 3
ClinicalTrials.gov
An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (FAP)
INTERVENTIONAL
Inicio: 26 de jun de 2014
ID: NCT02175004
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
INTERVENTIONAL
Inicio: 10 de jul de 2025
ID: NCT07011732
Completado
ClinicalTrials.gov
Impact of Fatigue in the Quality of Life of Patients With Multiple Sclerosis in Argentina
OBSERVATIONAL
Inicio: 1 de ago de 2008
ID: NCT01080001
Completado
Fase 3
ClinicalTrials.gov
A 12-month Double-blind, Randomized, Multicenter, Active-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Administered Orally Once Daily Versus Interferon ß-1a (Avonex) Administered im Once Weekly in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00340834
Reclutando
ClinicalTrials.gov
Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS
OBSERVATIONAL
Inicio: 1 de jul de 2022
ID: NCT05646394
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-Group, 26-Week, Phase 3 Study of 2 Doses of EVP-6124 or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication
INTERVENTIONAL
Inicio: 1 de oct de 2013
ID: NCT01969136
Desconocido
ClinicalTrials.gov
Real-world Patient Profile and Treatment Persistence of Ocrelizumab in Multiple Sclerosis: A Retrospective Analysis in Latin America
OBSERVATIONAL
Inicio: 1 de feb de 2019
ID: NCT03784547
Anterior
1
...
20
21
22
...
434
Siguiente
Filtros